Beyond Incidence and Mortality: Socioeconomic Mediation of Gastric Cancer Disparities in the United States, 1990–2021
Annals of Global Health · 2026
DOI: 10.5334/aogh.5015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Global Health, 2026. Verfasst von Yun Seo Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Health Status Disparities, Stomach Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gastric cancer (GC) remains a major global health burden, yet US trends often obscure disparities hidden within national averages. Although incidence and mortality have declined overall, profound geographic, racial, and socioeconomic differences persist. Few studies have systematically examined how demographic composition and social determinants jointly shape GC burden across states.
Methods
We analyzed Global Burden of Disease 2021 estimates for GC incidence, mortality, and disability‑adjusted life years (DALYs) from 1990 to 2021 across 50 US states and the District of Columbia. Outcomes were stratified by age, sex, race/ethnicity, and sociodemographic index. Multivariable and mediation models assessed how income and education modified racial and ethnic disparities.
Results
While national GC rates declined over three decades, the burden remained concentrated in states with large immigrant and low‑income populations, including Hawaii, the District of Columbia, Mississippi, and New Mexico. States with higher Asian populations exhibited roughly fourfold greater incidence than those with larger Hispanic populations. Income and education together mediated 22%–31% of racial and ethnic disparities, demonstrating that socioeconomic position—not race alone—drives much of the observed heterogeneity.
Conclusions
This state‑level sociodemographic analysis reveals the structural underpinnings of US GC inequities within a broader global context of uneven early‑life risk and population diversity. By linking racial composition, income, and education to disease burden, it identifies modifiable pathways for prevention and policy action. Viewed as a case study for migrant‑receiving countries, these findings underscore the importance of equity‑informed strategies—such as Helicobacter pylori screening, nutrition interventions, and targeted resource allocation—to address persistent GC disparities globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yonsei University College of Medicine, Seoul, Republic of Korea.
- Institute for Global Engagement & Empowerment, Yonsei University, Seoul, Republic of Korea.
- Severance Underwood Meta-Research Center, Institute of Convergence Science, Yonsei University, Seoul, Republic of Korea.
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
- Department of Pediatrics, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Kim, Y. S., Oh, S. S., Hong, S. H., Kim, M., Yon, D. K., Shin, J. I., & Hyun, C. S. (2026). Beyond Incidence and Mortality: Socioeconomic Mediation of Gastric Cancer Disparities in the United States, 1990–2021. Annals of Global Health. https://doi.org/10.5334/aogh.5015
Vancouver
Kim YS, Oh SS, Hong SH, Kim M, Yon DK, Shin JI, et al. Beyond Incidence and Mortality: Socioeconomic Mediation of Gastric Cancer Disparities in the United States, 1990–2021. Annals of Global Health. 2026. doi:10.5334/aogh.5015
BibTeX
@article{Kim2026,
author = {Kim, Yun Seo and Oh, Sarah Soyeon and Hong, Sung Hwi and Kim, Minseo and Yon, Dong Keon and Shin, Jae Il and Hyun, Chul S},
title = {Beyond Incidence and Mortality: Socioeconomic Mediation of Gastric Cancer Disparities in the United States, 1990–2021},
journal = {Annals of Global Health},
year = {2026},
doi = {10.5334/aogh.5015}
}
EUVIMED